VIEMED HEALTHCARE, INC. (VMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 30M 60M 90M Q1 '18: 14M Q2 '18: 15.5M Q3 '18: 17.2M Q4 '18: 18.4M Q1 '19: 18.1M Q2 '19: 20.3M Q3 '19: 20.4M Q4 '19: 21.4M Q1 '20: 23.8M Q2 '20: 42.9M Q3 '20: 33.4M Q4 '20: 31.2M Q1 '21: 28.4M Q2 '21: 27.4M Q3 '21: 29.3M Q4 '21: 32M Q1 '22: 32.3M Q2 '22: 33.3M Q3 '22: 35.8M Q4 '22: 37.5M Q1 '23: 39.6M Q2 '23: 43.3M Q3 '23: 49.4M Q4 '23: 50.7M Q1 '24: 50.6M Q2 '24: 55M Q3 '24: 58M Q4 '24: 60.7M Q1 '25: 59.1M Q2 '25: 63.1M Q3 '25: 71.9M Q4 '25: 76.2M Q1 '26: 75.4M Q2 '26: 78.1M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 20M 40M 60M Q1 '18: 10.4M Q2 '18: 11.3M Q3 '18: 13.1M Q4 '18: 13.5M Q1 '19: 13.1M Q2 '19: 14.6M Q3 '19: 14.1M Q4 '19: 14.2M Q1 '20: 15.6M Q2 '20: 25.9M Q3 '20: 19.5M Q4 '20: 19.2M Q1 '21: 17.7M Q2 '21: 17.6M Q3 '21: 18.4M Q4 '21: 19.7M Q1 '22: 19.7M Q2 '22: 20.4M Q3 '22: 21.7M Q4 '22: 22.9M Q1 '23: 24M Q2 '23: 26.1M Q3 '23: 30.6M Q4 '23: 32.1M Q1 '24: 29.8M Q2 '24: 32.9M Q3 '24: 34.4M Q4 '24: 36.1M Q1 '25: 33.3M Q2 '25: 36.7M Q3 '25: 41.3M Q4 '25: 44.1M Q1 '26: 42.8M Q2 '26: 45M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

0 5M 10M 15M Q1 '18: 2.3M Q2 '18: 2.6M Q3 '18: 2.7M Q4 '18: 2.9M Q1 '19: 2.3M Q2 '19: 1.7M Q3 '19: 2.2M Q4 '19: 2.7M Q1 '20: 4.6M Q2 '20: 12.9M Q3 '20: 4M Q4 '20: 5.3M Q1 '21: 1.3M Q2 '21: 2.7M Q3 '21: 2.9M Q4 '21: 4.7M Q1 '22: 2.2M Q2 '22: 1M Q3 '22: 1.5M Q4 '22: 3.5M Q1 '23: 1.9M Q2 '23: 2.9M Q3 '23: 4.2M Q4 '23: 5.3M Q1 '24: 2.2M Q2 '24: 3.6M Q3 '24: 5.6M Q4 '24: 6.5M Q1 '25: 3.8M Q2 '25: 5.1M Q3 '25: 5.6M Q4 '25: 8.4M Q1 '26: 4.3M Q2 '26: 4.5M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

0 7M 14M 21M Q1 '18: 2.3M Q2 '18: 2.4M Q3 '18: 2.4M Q4 '18: 3M Q1 '19: 2M Q2 '19: 1.3M Q3 '19: 2.9M Q4 '19: 2.4M Q1 '20: 4.2M Q2 '20: 19.4M Q3 '20: 2.8M Q4 '20: 5.1M Q1 '21: 1.7M Q2 '21: 1.6M Q3 '21: 1.8M Q4 '21: 4.1M Q1 '22: 1.8M Q2 '22: 967K Q3 '22: 1.1M Q4 '22: 2.4M Q1 '23: 1.5M Q2 '23: 2.3M Q3 '23: 2.9M Q4 '23: 3.5M Q1 '24: 1.6M Q2 '24: 1.5M Q3 '24: 3.9M Q4 '24: 4.3M Q1 '25: 2.6M Q2 '25: 3.2M Q3 '25: 3.5M Q4 '25: 5.6M Q1 '26: 2.6M Q2 '26: 2.8M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 15M 30M 45M Q1 '18: 3.6M Q2 '18: 4.2M Q3 '18: 4.1M Q4 '18: 4.8M Q1 '19: 5M Q2 '19: 5.7M Q3 '19: 6.3M Q4 '19: 7.2M Q1 '20: 8.3M Q2 '20: 16.9M Q3 '20: 14M Q4 '20: 12M Q1 '21: 10.7M Q2 '21: 9.8M Q3 '21: 10.9M Q4 '21: 12.3M Q1 '22: 12.5M Q2 '22: 12.9M Q3 '22: 14.1M Q4 '22: 14.6M Q1 '23: 15.6M Q2 '23: 17.2M Q3 '23: 18.8M Q4 '23: 18.6M Q1 '24: 20.8M Q2 '24: 22.1M Q3 '24: 23.6M Q4 '24: 24.6M Q1 '25: 25.9M Q2 '25: 26.3M Q3 '25: 30.6M Q4 '25: 32.1M Q1 '26: 32.6M Q2 '26: 33M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

0 8M 16M 24M Q3 '18: 5.2M Q4 '18: 8.2M Q1 '19: 650K Q2 '19: 5.3M Q3 '19: 5.7M Q4 '19: 7.4M Q1 '20: 607K Q2 '20: 21.4M Q3 '20: 7.3M Q4 '20: 5.8M Q1 '21: 4.6M Q2 '21: 4.2M Q3 '21: 5M Q4 '21: 8.7M Q1 '22: 7.1M Q2 '22: 4.9M Q3 '22: 8M Q4 '22: 7.7M Q1 '23: 10.5M Q2 '23: 7.6M Q3 '23: 13.8M Q4 '23: 13.3M Q1 '24: 1.2M Q2 '24: 10.2M Q3 '24: 12.7M Q4 '24: 15M Q1 '25: 2.9M Q2 '25: 12.3M Q3 '25: 18.4M Q4 '25: 18.4M Q1 '26: 8.1M Q2 '26: 15.9M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow Quarterly

-14M -7M 0 7M 14M 21M Q3 '18: 3.6M Q4 '18: 5.7M Q1 '19: 534K Q2 '19: -2.3M Q3 '19: 2.8M Q4 '19: 4.6M Q1 '20: -3.6M Q2 '20: 19.9M Q3 '20: 4.9M Q4 '20: 951K Q1 '21: 2.8M Q2 '21: 933K Q3 '21: -3M Q4 '21: 2M Q1 '22: 3.2M Q2 '22: -2.1M Q3 '22: 1.6M Q4 '22: 2.1M Q1 '23: 5.8M Q2 '23: 1.5M Q3 '23: 6.4M Q4 '23: 5.4M Q1 '24: -4.8M Q2 '24: 1.2M Q3 '24: 1.7M Q4 '24: 3.2M Q1 '25: -12.6M Q2 '25: 4.1M Q3 '25: 10.7M Q4 '25: 9.7M Q1 '26: 1.4M Q2 '26: 7.4M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '18: 39.3M Q3 '18: 39.9M Q1 '19: 39.4M Q2 '19: 40M Q3 '19: 40.1M Q4 '19: 40.1M Q1 '20: 39.7M Q2 '20: 40.8M Q3 '20: 41.2M Q4 '20: 41M Q1 '21: 40.7M Q2 '21: 41M Q3 '21: 40.7M Q1 '22: 40.4M Q2 '22: 39.8M Q3 '22: 39.6M Q1 '23: 40M Q2 '23: 40.7M Q3 '23: 40.4M Q1 '24: 40.6M Q2 '24: 40.6M Q3 '24: 40.8M Q1 '25: 41.6M Q2 '25: 41.1M Q3 '25: 40.5M Q1 '26: 40.5M Q2 '26: 41.1M Q1 '19 Q1 '20 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.30 0.60 0.90 Q4 '18: 0.25 Q1 '19: 0.24 Q2 '19: 0.21 Q3 '19: 0.22 Q4 '19: 0.21 Q1 '20: 0.27 Q2 '20: 0.72 Q3 '20: 0.72 Q4 '20: 0.78 Q1 '21: 0.71 Q2 '21: 0.27 Q3 '21: 0.24 Q4 '21: 0.22 Q1 '22: 0.22 Q2 '22: 0.20 Q3 '22: 0.19 Q4 '22: 0.16 Q1 '23: 0.16 Q2 '23: 0.20 Q3 '23: 0.24 Q4 '23: 0.25 Q1 '24: 0.25 Q2 '24: 0.23 Q3 '24: 0.26 Q4 '24: 0.29 Q1 '25: 0.31 Q2 '25: 0.35 Q3 '25: 0.34 Q4 '25: 0.37 Q1 '26: 0.37 Q2 '26: 0.36 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.